These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16940918)

  • 1. [Risk factors for incident cervical intraepithelial neoplasia (CIN) among HIV-infected women: a prospective study].
    Fridmann S; Boufassa F; Cartier I; Peretti D; Lazure T; Mole M; Delfraissy JF; Goujard C
    J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 1):490-6. PubMed ID: 16940918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
    Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
    Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical intraepithelial neoplasia treatment in Human Immunodeficiency Virus-positive women.
    Shah S; Montgomery H; Crow JC; Smith CJ; Moore A; Sabin CA; Evans H; Johnson MA
    J Obstet Gynaecol; 2008 Apr; 28(3):327-32. PubMed ID: 18569480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT; Macaluso M; Stalsberg H
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: Results of a prospective cohort study with up to 6.4 years of follow-up from India.
    Joshi S; Muwonge R; Kulkarni V; Deodhar K; Mandolkar M; Lucas E; Sankaranarayanan R
    Int J Cancer; 2019 Mar; 144(5):1082-1091. PubMed ID: 30132840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytology.
    Boardman LA; Cotter K; Raker C; Cu-Uvin S
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):238-43. PubMed ID: 18669717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.
    Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH
    Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for cervical intraepithelial neoplasia in HIV-infected women in Salvador, Bahia, Brazil.
    Oliveira PM; Oliveira RP; Travessa IÉ; Gomes MV; Santos ML; Grassi MF
    Sao Paulo Med J; 2010 Jul; 128(4):197-201. PubMed ID: 21120429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women.
    Delmas MC; Larsen C; van Benthem B; Hamers FF; Bergeron C; Poveda JD; Anzén B; van den Hoek A; Meier F; Peña JM; Savonius H; Sperandeo D; Suligoi B; Vernazza P; Brunet JB
    AIDS; 2000 Aug; 14(12):1775-84. PubMed ID: 10985315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
    Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ
    J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical intraepithelial neoplasia and invasive cancer risks in women infected with HIV in the French West Indies.
    Kadhel P; Multigner L; Bardinet F; Goerger-Sow M; Janky E
    HIV Med; 2012 Jan; 13(1):79-82. PubMed ID: 21819528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus.
    Fruchter RG; Maiman M; Sedlis A; Bartley L; Camilien L; Arrastia CD
    Obstet Gynecol; 1996 Mar; 87(3):338-44. PubMed ID: 8598951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
    Keller MJ; Burk RD; Massad LS; Eltoum IE; Hessol NA; Castle PE; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Levine AM; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
    Clin Infect Dis; 2015 Nov; 61(10):1573-81. PubMed ID: 26187020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.
    Cox JT; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2003 Jun; 188(6):1406-12. PubMed ID: 12824970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
    Videla S; Tarrats A; Ornelas A; Badia R; Castella E; Alcalde C; Chamorro A; Esté JA; Clotet B; Sirera G
    Int J STD AIDS; 2019 Jan; 30(1):56-63. PubMed ID: 30170532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population.
    Adam Y; van Gelderen CJ; de Bruyn G; McIntyre JA; Turton DA; Martinson NA
    BMC Cancer; 2008 Jul; 8():211. PubMed ID: 18657270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of High-Grade Cervical Lesions in Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology: Comparison between HIV-Infected and HIV-Negative Women.
    Srisomboon S; Tantipalakorn C; Muangmool T; Srisomboon J
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):547-551. PubMed ID: 33639672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.